SCHOTT PHARMA AG & CO. KGAA

Press Releases SCHOTT Pharma AG & Co. KGaA Deutsche Boerse AG

Equities

1SXP

DE000A3ENQ51

Market Closed - Deutsche Boerse AG Other stock markets 16:00:15 31/05/2024 BST			5-day change	1st Jan Change
29.28 ^EUR	+3.24%		-4.00%	-13.37%

05-28	SCHOTT PHARMA : Berenberg reiterates its Neutral rating	ZD
05-21	Deutsche Bank Research lowers target for Schott Pharma - 'Buy'	DP

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-23	EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-23	EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-17	EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-17	EQ
SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes	05-14	EQ
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes	05-14	EQ
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations	04-30	EQ
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina	03-19	AQ
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility	03-18	EQ
Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda	03-14	EQ
DD: SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, sell	03-04	EQ
SCHOTT Pharma reports good start into fiscal year 2024	02-29	EQ
AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements	02-26	EQ
SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory	01-26	EQ
AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	01-15	EQ
SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance	12-19	EQ
Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company	12-06	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW